CYTOSORBENTS CORPORATION Effective Tax Rate
CYTOSORBENTS CORPORATION (CTSO) reported Effective Tax Rate of 4.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-30
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, percent for fiscal 2025 was 4.70%, a 38.16% decline from fiscal 2024.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, percent for fiscal 2024 was 7.60%, a 181.48% increase from fiscal 2023.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, percent for fiscal 2023 was 2.70%, a 15.63% decline from fiscal 2022.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, percent for fiscal 2022 was 3.20%, a 14.29% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 4.70% 10-K · filed 2026-03-30 | |
| 2024-12-31 | 7.60% 10-K · filed 2026-03-30 | |
| 2023-12-31 | 2.70% 10-K · filed 2025-03-31 | 2.80% 10-K · filed 2024-03-15 |
| 2022-12-31 | 3.20% 10-K · filed 2024-03-15 | 0.03% 10-K · filed 2023-03-09 |
| 2021-12-31 | 2.80% 10-K · filed 2024-03-15 | |
| 2020-12-31 | 0.13% 10-K · filed 2023-03-09 | 12.60% 10-K · filed 2021-03-09 |
| 2019-12-31 | 5.40% 10-K · filed 2022-03-10 | |
| 2018-12-31 | 3.20% 10-K · filed 2021-03-09 | |
| 2017-12-31 | 7.30% 10-K · filed 2020-03-05 | |
| 2016-12-31 | 2.60% 10-K · filed 2019-03-07 | |
| 2015-12-31 | 3.80% 10-K · filed 2018-03-08 | -3.80% 10-K · filed 2016-03-09 |
| 2014-12-31 | 0.00% 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |